Adaptive Biotechnologies Corporation (ADPT) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Adaptive Biotechnologies Corporation  (NASDAQ: ADPT)


Adaptive Biotechnologies's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Adaptive Biotechnologies's ROI in the third quarter of 2026?
Adaptive Biotechnologies Corporation recorded a cumulative net loss of $-71 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -14.07%.

Within the Healthcare sector 142 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 3162, from total ROI ranking in the second quarter of 2026 at 3757.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 19.88 % 4.87 % -8.95 % -14.51 % -19.36 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 592 561 427 429 407
Return On Investment (TTM) -14.07 % -14.04 % -11.91 % -14.3 % -19 %
ADPT's Overall Ranking # 3162 # 3757 # 3406 # 3581 # 3675
Seq. Investment Change TTM 10.13 % 9.38 % 0.24 % -0.72 % -3.66 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -71 -64 -50 -59 -80

ADPT Company Profile >> Back to ADPT Roi Comparisons >> See Annual ADPT Return On Investment



Return On Investment ADPT's Ranking
Within: No.
Industry # 17
Sector # 143
Overall # 3162

Return On Investment Statistics
High Average Low
28.22 %
-12.98 %
-35.55 %
(Jun 30 2016)   (Jun 30 2024)







Financial Statements
Adaptive Biotechnologies's III. Quarter Investments $ 592 Millions ADPT's Balance sheet
Adaptive Biotechnologies's III. Quarter Income $ 3 Millions Quarterly ADPT's Income Statement
ADPT's Income by Division See ADPT's Income by Division


ADPT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 429 441 573 747 810
Y / Y Investment Growth -2.74 % -23.02 % -23.27 % -7.77 % -19.93 %
Net Income in Millions -59 -160 -225 -200 -207
Y / Y Net Income Growth - - - - -
Annual Return On Investment -13.86 % -36.18 % -39.32 % -26.83 % -25.6 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ADPT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ADPT's Competitors
Subscribers only: Roi for Adaptive Biotechnologies's Suppliers
Subscribers only: Return On Investment for ADPT's Customers

Other Ratios
ADPT's Roa ADPT's Inventory Turnover Ratio ADPT's Growth Rates ADPT's Dividend Statistics
ADPT's Profitability Ratios ADPT's Asset Turnover Ratio ADPT's Dividend Growth
ADPT's Roe ADPT's Valuation Ratios ADPT's Financial Strength Ratios ADPT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI

Date modified: 2026-11-07T13:20:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.